M&A TRANSACTION · 2019
RoseRock Healthcare acquired by Amedisys, Inc.
$17.5M· Hospice
Disclosed financials at time of acquisition
Revenue
$10.0M
EBITDA
$2.0M
Deal Value
$17.5M
What's your hospice worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $17.5M acquisition of RoseRock Healthcare by Amedisys, Inc. sits in the hospice sub-vertical. Run a valuation for your own hospice business via our Hospice valuation hub. Amedisys, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price hospice businesses on our Hospice strategic buyer-pool page.
Source
Data sourced from SEC filings and cost reports. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own hospice
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the RoseRock Healthcare acquisition.
More on hospice valuations
- Value a hospice· run the calculator
- Hospice median multiples· real-deal benchmarks
- Who buys hospice businesses?· active buyers
- Who acquired Agape Care Group?· buyer profile
- How to value a hospice· long-form guide